
BNRPF
Real Estate · Real Estate - Development · $195.2M market cap
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2021
EPS trend, 90 days to now · +14.4% over 90 days · 30-day revisions 0 up, 0 down
Beat estimates in 3 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 16, 2021 | After the close | 0.40 | 0.69 | +72.5% |
| Aug 24, 2021 | After the close | 0.28 | 0.13 | -53.6% |
| Apr 27, 2021 | After the close | 1.23 | 1.62 | +31.7% |
| Feb 23, 2021 | After the close | 2.23 | 3.28 | +47.1% |
| Nov 10, 2020 | After the close | 1.48 | -0.58 | -139.2% |
| Aug 25, 2020 | After the close | -0.21 | -0.52 | -147.6% |
| May 26, 2020 | After the close | -0.33 | -1.00 | -203.0% |
| Feb 25, 2020 | After the close | 0.16 | 0.69 | +331.3% |
| Oct 29, 2019 | After the close | 0.84 | 0.29 | -65.5% |
| Aug 13, 2019 | After the close | 0.76 | 1.16 | +52.6% |
| May 14, 2019 | After the close | 0.21 | -0.15 | -171.4% |
| Feb 26, 2019 | After the close | -0.27 | -0.21 | +22.2% |
| Nov 6, 2018 | After the close | 0.99 | 1.18 |
Solon Eiendom ASA acquires, develops, and sells residential real estate properties in Norway. The company was formerly known as Bionor Pharma ASA and changed its name to Solon Eiendom ASA. The company was founded in 2006 and is based in Oslo, Norway. Solon Eiendom ASA is a subsidiary of Samhällsbyggnadsbolaget i Norden AB (publ). As on January 20, 2022, Solon Eiendom ASA was taken private.
| +19.2% |
| Aug 21, 2018 | After the close | -0.27 | -0.05 | +81.5% |
| May 15, 2018 | After the close | 1.18 | 1.60 | +35.6% |
| Feb 27, 2018 | After the close | 0.73 | 0.54 | -26.0% |